ArticlePharmaceutics2025

Synthesis and Characterization of Transferrin Receptor-Targeted Peptide Combination SN-38 and Rucaparib Conjugate for the Treatment of Glioblastoma.

Perpetue Bataille Backer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.